This document provides definitions, guidelines, a framework and a risk-based approach for the design, selection and validation for methods for rapid microbial detection cellular therapeutic product manufacturing.
This document contains the generalized requirements and risks associated with cellular therapeutic product manufacturing, with flexibility to address differences in specific manufacturing processes of each unique cellular therapeutic product.
This document primarily addresses sterility testing in cellular therapeutic product manufacturing. This document can be applied to other cell derived therapeutic product manufacturing.
This document focuses on rapid microbial test methods (RMTMs) used in both in-process and final product testing.
Viral testing in cell-based therapy manufacturing is not included in this document.
Status: Under developmentPublication date: 2023-05
Technical Committee: ISO/TC 276 Biotechnology
- ICS :
- 07.080 Biology. Botany. Zoology
This standard contributes to the following Sustainable Development Goals:
ISO 24190Stage: 60.00 (Under publication)
Got a question?
Check out our FAQs
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)
Keep up to date with ISO
Sign up to our newsletter for the latest news, views and product information.